SJS Investment Consulting
CLB icon

SJS Investment Consulting’s Core Laboratories CLB Stock Holding History

SJS Investment Consulting’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$49 Sell
5
-3
-38% -$35 ﹤0.01% 3120
2026
Q2 		$94 Buy
+8
New +$114 ﹤0.01% 2625

Other funds holding CLB

Ariel Investments
Ariel Investments Chicago, Illinois $9.6B AUM 22.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $25.4B AUM 35.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
GJL
Gendell Jeffrey L $9.6B AUM 75.6% 1-Year Est. Return
Heartland Advisors
Heartland Advisors Milwaukee, Wisconsin $2.08B AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

SJS Investment Consulting's CLB Position: Q3 2026 in Review

SJS Investment Consulting reduced its Core Laboratories (CLB) stake by 38% in Q3 2026, selling an estimated $35 and leaving 5 shares worth $49. The position accounts for ﹤0.01% of the portfolio, ranked #3120.

SJS Investment Consulting first reported a position in CLB in Q2 2026 and has held it in 2 quarters since. The position peaked at $94 in Q2 2026. 131 funds tracked by Wall St. Rank hold CLB as of Q3 2026.

  • SJS Investment Consulting held 5 shares of Core Laboratories worth $49 as of Q3 2026.
  • SJS Investment Consulting sold 3 Core Laboratories shares in Q3 2026, an estimated $35.
  • Core Laboratories made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #3120 holding.
  • SJS Investment Consulting first reported a position in Core Laboratories in Q2 2026 and has held it in 2 quarters since.
  • SJS Investment Consulting's Core Laboratories position peaked at $94 in Q2 2026.
  • 131 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.